Trial Profile
Randomized study comparing everolimus- and sirolimus-eluting stents in patients with bifurcation lesions treated by provisional side-branch stenting
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 26 Mar 2013
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Sirolimus
- Indications Cardiovascular disorders; Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- 26 Mar 2013 New trial record